bupropion has been researched along with Brown Tendon Sheath Syndrome in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cartier R, L | 1 |
| Romero O, C | 1 |
| Pérez P, G | 1 |
| Singman, EL | 1 |
| Hocum, B | 1 |
| Yohannan, J | 1 |
| Pearson, V | 1 |
2 other studies available for bupropion and Brown Tendon Sheath Syndrome
| Article | Year |
|---|---|
[Sustained upgaze in a patient who ingested high doses of bupropion. Report of one case].
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Coma; Drug Overdose; Fatal Outcome; Femal | 2018 |
Fluvoxamine-associated oscillopsia and a role for personalized medication dosing.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Depressive Disorder; Dopa | 2015 |